A novel deletion mutation of SLC16A2 encoding monocarboxylate transporter (MCT) 8 in a 26-yearold Japanese patient with Allan-Herndon-Dudley syndrome

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Allan-Herndon-Dudley Syndrome (AHDS), an X linked condition, is characterized by congenital hypotonia that progresses to spasticity with severe psychomotor delays, in combination with altered thyroid hormone levels, in particular, high serum T3 levels. Recently, this disease was proved to be caused by mutations in SLC16A2 coding for the monocarboxylate thyroid hormone transporter 8 (MCT8). Here we describe a 26-year -old Japanese patient with AHDS who had deletion of exon 3 of SLC16A2. © 2013 by The Japanese Society for Pediatric Endocrinology.

Cite

CITATION STYLE

APA

Yamamoto, S., Okuhara, K., Tonoki, H., Iizuka, S., Nihei, N., & Tajima, T. (2013). A novel deletion mutation of SLC16A2 encoding monocarboxylate transporter (MCT) 8 in a 26-yearold Japanese patient with Allan-Herndon-Dudley syndrome. Clinical Pediatric Endocrinology, 22(4), 83–86. https://doi.org/10.1297/cpe.22.83

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free